Park Avenue Securities’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,510
Closed -$305K 1213
2022
Q3
$305K Buy
3,510
+393
+13% +$41.3K 0.01% 899
2022
Q2
$355K Buy
3,117
+532
+21% +$61.1K 0.01% 841
2022
Q1
$335K Sell
2,585
-39
-1% -$5.62K 0.01% 908
2021
Q4
$473K Buy
2,624
+549
+26% +$95.2K 0.01% 734
2021
Q3
$308K Buy
2,075
+188
+10% +$28.8K 0.01% 842
2021
Q2
$286K Buy
1,887
+179
+10% +$24.9K 0.01% 856
2021
Q1
$222K Buy
+1,708
New +$219K 0.01% 894

Other funds holding OMCL

Park Avenue Securities's OMCL Position: Q4 2022 in Review

Park Avenue Securities sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 3,510 shares — an estimated $305K sold.

Park Avenue Securities first reported a position in OMCL in Q1 2021 and held it in 7 quarters. The position peaked at $473K in Q4 2021. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Park Avenue Securities reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Park Avenue Securities sold 3,510 Omnicell shares in Q4 2022, an estimated $305K.
  • Park Avenue Securities first reported a position in Omnicell in Q1 2021 and held it in 7 quarters.
  • Park Avenue Securities's Omnicell position peaked at $473K in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Park Avenue Securities's 13F filing for Q4 2022, filed 24 Jan 2023.